This website uses cookies to enhance the user experience.
||
GOLDENEYE AS

GOLDENEYE AS992 763 914

Limited company
Frydenlundgata 3A 0169 OSLO, Norge

GOLDENEYE AS

Operating
Forsiden - Norisma
COMING SOON! Kjære kunde, Helt fra start har vi som selskap hatt 2 klare formål. Det ene var å tilby kvalitetstilskudd til fornuftige priser, ved å kutte bindeleddet med fysiske butikker og kun selge våre merkevarer på nett. Det andre var å bringe spennende trender innen helse og skjønnhet fra resten av verden til hjem…
Å eie aksjer, finansielle investeringer, eiendom og utvikle strategiske allianser etc, samt annen virksomhet som naturlig faller inn under dette.

Organization

CEO
OA

Omar Ali Paulsen Bekheet1983

Chairman of the board
OA

Omar Ali Paulsen Bekheet1983

Years since formation
18 years
since Jun 9, 2008
Type
Limited company
VAT registered
No
Number of employees
0

Ownership

Number of shares and share classes
40,666
1 share class
Total number of shareholders
1
person
Belongs to group of

Financials

Annual total result 2025
74,784,501
NOK
Total equity 2025
77,798,687
NOK
Last update: May 9, 2026

Management

Management / administration

NameRoleShares
OA

Omar Ali Paulsen Bekheet

1983

Managing Director/CEO
100 %
directly

Board

NameRoleShares
OA

Omar Ali Paulsen Bekheet

1983

Chairman
100 %
directly

Others

NameRoleShares
W
WELLINGTON AS
Accountant-

Top 10 individual shareholders

NameRoleShares
OA

Omar Ali Paulsen Bekheet

1983

Managing Director/CEO, Chairman
100 %
directly
Last update: Apr 13, 2023

Ownership

Company shareholders

NameShare classTotal number of sharesShare
OA

Omar Ali Paulsen Bekheet

1983

Ordinary shares
40,666
100 %

Shares owned by the GOLDENEYE AS

NameShare classTotal number of sharesShare
C
CEMENTARY AS
Ordinary shares
30,000
100 %
B
BEKHEET EIENDOM AS
Ordinary shares
30,000
100 %
S
SPOTTEN AS
Closed
Ordinary shares
1,047
39.99 %
N
NUTRICOS GROUP AS
Closed
Ordinary shares
78,079
39.04 %
B
BEVIVO AS
Ordinary shares
9,135
30.45 %
F
FESENSO AS
Ordinary shares
331
26.48 %
W
WAIVE AS
Ordinary shares
45
0.07 %
N
NORQUANT AS
Ordinary shares
13,819
0.04 %
L
LYTIX BIOPHARMA ASA
NO0010405780
450
< 0.01 %
Last update: Jun 2, 2025

Group structure

  • GOLDENEYE AS
    Total operating income 2025: NOK 0
    Operating profit 2025: NOK -1,031,711
    Employees: 0

Financials

in NOK

Summary

Year20252024202320222021
Total operating income
0
0
0
0
0
Annual Total Result
74,784,501
118,972
-162,559
272,972
1,219,633
Total assets
84,809,404
4,305,976
3,801,635
5,080,717
5,903,438
Total liabilities
7,010,717
444,791
59,421
355,943
1,101,637
Total equity
77,798,687
3,861,186
3,742,214
4,724,774
4,801,802

P&L

Year20252024202320222021
Total operating income
0
0
0
0
0
Total operating costs
1,031,711
19,541
24,336
28,310
21,098
Operating result
-1,031,711
-19,541
-24,336
-28,310
-21,098
Financial income/costs
75,816,212
145,012
-142,107
303,471
1,229,371
Profit before tax
74,784,501
125,472
-166,442
275,161
1,208,273
Total tax & extraordinary income/cost
0
6,500
-3,883
2,189
-11,360
Annual Total Result
74,784,501
118,972
-162,559
272,972
1,219,633

Balance overview

Year20252024202320222021
Total fixed assets
11,940,131
2,337,328
2,860,193
2,508,393
1,506,337
Total current assets
72,869,273
1,968,648
941,442
2,572,323
4,397,102
Total assets
84,809,404
4,305,976
3,801,635
5,080,717
5,903,438
Short term debt
7,010,717
444,791
59,421
351,252
1,099,135
Long term debt
0
0
0
4,691
2,502
Total liabilities
7,010,717
444,791
59,421
355,943
1,101,637
Contributed capital
158,634
158,634
158,634
158,634
158,634
Retained earnings
77,640,053
3,702,552
3,583,580
4,566,140
4,643,168
Total equity
77,798,687
3,861,186
3,742,214
4,724,774
4,801,802
Total equity and liabilities
84,809,404
4,305,976
3,801,635
5,080,717
5,903,438

Classification

21st company classification
BETA
Small company
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises